Loading
Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares DESTINY-PanTumor02: trastuzumab deruxtecan in HER2-expressing solid tumours, DESTINY-PanTumor02, Sacituzumab tirumotecan, Robotic & minimally invasive surgery and the tag subtype-page.
Shares DESTINY-PanTumor02: trastuzumab deruxtecan in HER2-expressing solid tumours, DESTINY-PanTumor02, Robotic & minimally invasive surgery, Trastuzumab deruxtecan and the tag subtype-page.
Shares A Study of BL-B01D1 + Pembrolizumab ± Bevacizumab in Patients With Recurrent or Metastatic Cervical Cancer and Endometrial Cancer, DESTINY-PanTumor02, Sacituzumab tirumotecan, Trastuzumab deruxtecan and the tag subtype-page.
Shares Sacituzumab tirumotecan, Robotic & minimally invasive surgery, Paclitaxel / nab-paclitaxel, IMRT / IGRT (modern external beam) and the tag subtype-page.
Shares Topotecan, PD-L1, Bevacizumab, Gemcitabine and the tag subtype-page.
Shares Cemiplimab, PD-L1, IMRT / IGRT (modern external beam), Carboplatin and the tag subtype-page.
Shares Lifileucel, IMRT / IGRT (modern external beam), Cisplatin, Pembrolizumab and the tag subtype-page.
Shares Bevacizumab, Gemcitabine, Paclitaxel / nab-paclitaxel, IMRT / IGRT (modern external beam) and the tag subtype-page.
The same record for scripts and assistants; checked 2026-09-17. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.